(Q89707188)
Statements
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients (English)
Johan Askling
Joachim Burman
Katharina Fink
Anna Fogdell-Hahn
Martin Gunnarsson
Jan Hillert
Annette Langer-Gould
Jan Lycke
Petra Nilsson
Jonatan Salzer
Anders Svenningsson
Magnus Vrethem
Tomas Olsson
13 February 2020